US Bancorp
RPTX

US Bancorp’s Repare Therapeutics RPTX Stock Holding History

US Bancorp’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-533
Closed -$6.44K – 4124
2023
Q3 		$6.44K Hold
533
– – ﹤0.01% 3340
2023
Q2 		$5.64K Buy
533
+207
+63% +$2.13K ﹤0.01% 3452
2023
Q1 		$3.21K Buy
326
+30
+10% +$344 ﹤0.01% 3652
2022
Q4 		$4.35K Sell
296
-119
-29% -$1.78K ﹤0.01% 3563
2022
Q3 		$5K Sell
415
-378
-48% -$4.87K ﹤0.01% 3614
2022
Q2 		$11K Buy
+793
New +$9.34K ﹤0.01% 3344
2020
Q3 		– Sell
-200
Closed -$6K – 3825
2020
Q2 		$6K Buy
+200
New +$6.42K ﹤0.01% 3265

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

US Bancorp's RPTX Position: Q4 2023 in Review

US Bancorp sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 533 shares — an estimated $6.44K sold.

US Bancorp first reported a position in RPTX in Q2 2020 and held it in 7 quarters. The position peaked at $11K in Q2 2022. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • US Bancorp reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • US Bancorp sold 533 Repare Therapeutics shares in Q4 2023, an estimated $6.44K.
  • US Bancorp first reported a position in Repare Therapeutics in Q2 2020 and held it in 7 quarters.
  • US Bancorp's Repare Therapeutics position peaked at $11K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.